SJS Investment Consulting »

Protara Therapeutic shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $42 8 5.25

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Total Eq (AVTM)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Global Real Est (DFGR)

View all positions for SJS Investment Consulting

Top funds holding Protara Therapeutic

Henderson Group
BlackRock
Velan Capital Investment Management
Millennium Management
Vanguard Group
Blackstone Group
Integral Health Asset Management
Vanguard Capital Management
Acorn Capital Advisors
Sio Capital Management
AIGH Capital Management
UBS Group
5AM Venture Management
Driehaus Capital Management
Citadel Advisors

View all funds holding Protara Therapeutic